Search Results 201-210 of 17112 for monoclonal antibody

  1. Infliximab-qbtx (intravenous route) - Side effects & uses - Mayo Clinic

    Infliximab-qbtx is a monoclonal antibody that works to enhance and improve the immune system. This medicine is to be given only by or under the direct ...

  2. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may block tumor growth in ... Prior anti-cancer therapy with a monoclonal antibody (mAb) ≤ 4 weeks prior ...

  3. Potential one-time gene therapy treatment for wet age-related macular degeneration - Mayo Clinic

    ... monoclonal antibody fragment," says Dr. Bakri. "The expressed protein is designed to neutralize vascular endothelial growth factor (VEGF) activity. Anti ...

  4. Telisotuzumab vedotin-tllv (intravenous route) - Side effects & uses - Mayo Clinic

    Telisotuzumab vedotin-tllv injection is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is ...

  5. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  6. Tackling the latest COVID-19 topics - Mayo Clinic News Network

    Antibody tests after having a COVID-19 vaccine. Monoclonal antibodies. COVID-19 variants. Side effects, especially after the second dose of a COVID-19 ...

  7. Publications - Angie N. Ton, M.D. - Mayo Clinic

    Ton A, Francis D, Speicher L. COVID-19 Patient Acceptance to Monoclonal Antibody Infusion: A Single Medical Center Experience. South Med J 2021 Aug; 114 (8): ...

  8. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability of the combination of idelallisib with the monoclonal antibody BI ...

  9. Blistering Clinical Trials - Mayo Clinic Research

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  10. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    Copanlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as nivolumab, may interfere ...